Skip to content

Bristol-Myers Squibb BMY Balance Sheet Statement

Q1 '26Q4 '25Q3 '25Q2 '25Q1 '25
$9.57B-6.2%$10.21B-35.1%$15.73B+24.8%$12.6B+15.9%$10.88B+5.1%
$912M+96.6%$464M-40.2%$776M-22.7%$1B+10.7%$907M+76.8%
$9.37B-17.9%$11.41B-0.1%$11.42B+0.1%$11.42B+5.7%$10.8B+0.5%
$2.76B+2.5%$2.69B-2.5%$2.76B+0.8%$2.74B+2.7%$2.67B+4.3%
$27.21B-7.4%$29.39B-17.5%$35.63B+7.2%$33.22B+7.9%$30.78B+3.4%
$7.66B+1.5%$7.54B+2.6%$7.35B-0.3%$7.37B+2.2%$7.21B+1.1%
$21.74B-0.1%$21.75B0.0%$21.75B-0.1%$21.78B+0.2%$21.74B+0.1%
$86.48B-4.0%$90.04B-7.1%$96.89B+2.3%$94.68B+2.4%$92.43B-0.2%
$4.23B+18.4%$3.58B-16.6%$4.29B-21.0%$5.43B+35.6%$4B+11.1%
$2.31B+2.1%$2.26B-49.9%$4.51B-4.4%$4.72B+32.7%$3.55B+73.7%
$2.31B+2.1%$2.26B-49.9%$4.51B-4.4%$4.72B+32.7%$3.55B+73.7%
$19.16B-18.2%$23.42B-16.8%$28.14B+2.2%$27.53B+14.4%$24.07B+1.2%
$42.15B-1.6%$42.85B-3.6%$44.47B0.0%$44.47B-3.7%$46.16B-3.0%
$66.37B-7.2%$71.53B-8.6%$78.29B+1.4%$77.19B+2.9%$74.98B-1.6%
$292M0.0%$292M0.0%$292M0.0%$292M0.0%$292M0.0%
$18.29B+8.2%$16.9B-1.2%$17.09B+5.8%$16.15B+0.3%$16.11B+8.0%
$20.07B+8.6%$18.47B-0.4%$18.55B+6.4%$17.44B+0.3%$17.39B+6.5%
$86.48B-4.0%$90.04B-7.1%$96.89B+2.3%$94.68B+2.4%$92.43B-0.2%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

What are Bristol-Myers Squibb's total assets?
Bristol-Myers Squibb (BMY) holds $86.5B in total assets, down 6.4% year over year.
How much debt does Bristol-Myers Squibb have?
Bristol-Myers Squibb carries $44.7B in total debt against $20.1B of shareholders' equity, a debt-to-equity ratio of 2.23.
How much cash does Bristol-Myers Squibb have?
Bristol-Myers Squibb holds $9.6B in cash and equivalents.
Can Bristol-Myers Squibb cover its short-term obligations?
Its current ratio is 1.42 — current assets exceed current liabilities.
Where does Bristol-Myers Squibb's balance sheet data come from?
Every line is extracted from Bristol-Myers Squibb's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.